Cargando…

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies

SIMPLE SUMMARY: SMARCA4-mutated tumors are associated with poor prognosis. However, it is not clear if male and female patients have the same or different prognosis and if additional common mutations within the tumor play a role in prognosis. We have found that male patients had substantially worse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Minggui, Jiang, Chen, Zhang, Zheyang, Achacoso, Ninah, Solorzano-Pinto, Aleyda V., Tse, Pam, Chung, Elaine, Suga, Jennifer Marie, Thomas, Sachdev, Habel, Laurel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216441/ https://www.ncbi.nlm.nih.gov/pubmed/37345003 http://dx.doi.org/10.3390/cancers15102665

Ejemplares similares

Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947–2009)
por: Krieger, Nancy, et al.
Publicado: (2015)

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
por: Habel, Laurel A, et al.
Publicado: (2013)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma
por: Pottegård, Anton, et al.
Publicado: (2016)

Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting
por: Habel, Laurel A, et al.
Publicado: (2009)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

Case-control study of mammographic density and breast cancer risk using processed digital mammograms
por: Habel, Laurel A., et al.
Publicado: (2016)

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015)

SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis
por: Liu, Liang, et al.
Publicado: (2020)

MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer
por: Song, Xiaoyu, et al.
Publicado: (2023)

SMARCA4 germline gene mutation in a patient with epithelial ovarian: A case report
por: Muppala, Reshma, et al.
Publicado: (2017)

Dominant-negative SMARCA4 missense mutations alter the accessibility landscape of tissue-unrestricted enhancers
por: Hodges, H. Courtney, et al.
Publicado: (2017)

New SMARCA2 mutation in a patient with Nicolaides–Baraitser syndrome and myoclonic astatic epilepsy
por: Tang, S., et al.
Publicado: (2016)

Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature review
por: Pastorczak, Agata, et al.
Publicado: (2021)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
por: Sun, Lijun, et al.
Publicado: (2023)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma
por: Levy, Michelle, et al.
Publicado: (2017)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness
por: Homann, Oliver R, et al.
Publicado: (2016)

A SMARCA2 Mutation in the First Case Report of Nicolaides-Baraitser Syndrome in Latin America: Genotype-Phenotype Correlation
por: Sánchez, Ana Isabel, et al.
Publicado: (2017)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020)

SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
por: Wagner, Samantha Kay, et al.
Publicado: (2023)

SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
por: Al-Shbool, Ghassan, et al.
Publicado: (2022)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)

Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation
por: Yin, Xin, et al.
Publicado: (2022)

SMARCA4 inactivating mutations cause concomitant Coffin–Siris syndrome, microphthalmia and small‐cell carcinoma of the ovary hypercalcaemic type
por: Errichiello, Edoardo, et al.
Publicado: (2017)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
por: Tagal, Vural, et al.
Publicado: (2017)

The Emerging Roles of circSMARCA5 in Cancer
por: Qin, Haoyu, et al.
Publicado: (2022)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Highly aggressive undifferentiated small round blue cell tumor of foot with unique SMARCA1, KAT6A and NAV3 mutations
por: Parsa, Cyrus, et al.
Publicado: (2019)

Generation of an iPSC line (CRICKi001-A) from an individual with a germline SMARCA4 missense mutation and autism spectrum disorder
por: Devito, Liani G., et al.
Publicado: (2021)

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations
por: Sanders, Brooke E., et al.
Publicado: (2022)

Sex-specific association of SH2B3 and SMARCA4 polymorphisms with coronary artery disease susceptibility
por: Ji, Yuqiang, et al.
Publicado: (2017)

Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis
por: Chao, Fan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p3lfmc2nasi8624u700ahatgal